Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube.
AuthorsGriffiths, Richard W
Mitchell, Claire L
Kumaran, Gireesh C
Jayson, Gordon C
Clamp, Andrew R
AffiliationDepartments of *Medical Oncology, and †Clinical Oncology, The Christie NHS Foundation Trust; and ‡School of Cancer and Enabling Science, University of Manchester, Manchester, UK.
MetadataShow full item record
Abstract: Platinum-resistant and refractory cancers of the ovary, fallopian tube, and peritoneum have a poor prognosis, yet in some cases, they can respond to multiple lines of chemotherapy. Uncertainty remains over optimal drug choice and when therapeutic focus should be switched from active therapy to supportive care.
CitationOutcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube. 2011, 21 (1):58-65 Int. J Gynecol Cancer
JournalInternational Journal of Gynecological Cancer